Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Hajaj

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cold Spring Harbor Perspectives in Medicine|September 11, 2023
From the Inside Out: Exposing the Roles of Urea Cycle Enzymes in Tumors and Their Micro and Macro EnvironmentsEmma Hajaj, Sabina Pozzi, Ayelet Erez
Molecular Cell|September 1, 2021
The context-specific roles of urea cycle enzymes in tumorigenesisEmma Hajaj, Marco Sciacovelli, Christian Frezza, et al.
Cancer Immunology Research|January 7, 2018
Soluble SLAMF6 Receptor Induces Strong CD8<sup>+</sup> T-cell Effector Function and Improves Anti-Melanoma Activity <i>In Vivo</i>Galit Eisenberg, Roni Engelstein, Anat Geiger-Maor, et al.
Frontiers in Oncology|March 3, 2020
Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma-A Retrospective StudyReut Hadash-Bengad, Emma Hajaj, Shiri Klein, et al.
Immunologic Research|July 22, 2022
The role of immune checkpoint receptors in the malignant phenotype of cutaneous T cell lymphomaRony Shreberk-Hassidim, Anat Geiger-Maor, Galit Eisenberg, et al.
Elife|March 4, 2020
SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpointEmma Hajaj, Galit Eisenberg, Shiri Klein, et al.
Cancer Immunology Research|March 25, 2021
Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector FunctionsEmma Hajaj, Elad Zisman, Shay Tzaban, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2021
<i>TP53</i> missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironmentMartino Maddalena, Giuseppe Mallel, Nishanth Belugali Nataraj, et al.
Cancer Discovery|March 27, 2023
Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic CarcinogenesisOmer Goldman, Lital N Adler, Emma Hajaj, et al.
Nature Metabolism|June 10, 2024
ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage responseLisha Qiu Jin Lim, Lital Adler, Emma Hajaj, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cold Spring Harbor Perspectives in Medicine|September 11, 2023
From the Inside Out: Exposing the Roles of Urea Cycle Enzymes in Tumors and Their Micro and Macro EnvironmentsEmma Hajaj, Sabina Pozzi, Ayelet Erez
Molecular Cell|September 1, 2021
The context-specific roles of urea cycle enzymes in tumorigenesisEmma Hajaj, Marco Sciacovelli, Christian Frezza, et al.
Cancer Immunology Research|January 7, 2018
Soluble SLAMF6 Receptor Induces Strong CD8<sup>+</sup> T-cell Effector Function and Improves Anti-Melanoma Activity <i>In Vivo</i>Galit Eisenberg, Roni Engelstein, Anat Geiger-Maor, et al.
Frontiers in Oncology|March 3, 2020
Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma-A Retrospective StudyReut Hadash-Bengad, Emma Hajaj, Shiri Klein, et al.
Immunologic Research|July 22, 2022
The role of immune checkpoint receptors in the malignant phenotype of cutaneous T cell lymphomaRony Shreberk-Hassidim, Anat Geiger-Maor, Galit Eisenberg, et al.
Elife|March 4, 2020
SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpointEmma Hajaj, Galit Eisenberg, Shiri Klein, et al.
Cancer Immunology Research|March 25, 2021
Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector FunctionsEmma Hajaj, Elad Zisman, Shay Tzaban, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2021
<i>TP53</i> missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironmentMartino Maddalena, Giuseppe Mallel, Nishanth Belugali Nataraj, et al.
Cancer Discovery|March 27, 2023
Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic CarcinogenesisOmer Goldman, Lital N Adler, Emma Hajaj, et al.
Nature Metabolism|June 10, 2024
ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage responseLisha Qiu Jin Lim, Lital Adler, Emma Hajaj, et al.
Pageof 2